RARA CRAFT DATABASE for FDA Medical Devices
510(k)K223640

FDA DEVICE FACTS

Axoguard HA+ Nerve Protector (AGHA12); Axoguard HA+ Nerve Protector (AGHA22); Axoguard HA+ Nerve Protector (AGHA24); Axoguard HA+ Nerve Protector (AGHA36); Axoguard HA+ Nerve Protector (AGHA48)

Axogen Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 7, 2023PRODUCT CODEJXI

Indications for use

Axoguard HA+ Nerve Protector is indicated for the management of peripheral nerve injuries where there is no gap. Axoguard Nerve Protector is indicated for the repair of peripheral nerve injuries in which there is no gap or where a gap closure is achieved by flexion of the extremity. The device is provided sterile and intended for one-time use. Dimensions Width (cm) Length (cm) Area (cm2) 1 2 2 2 2 4 2 4 8 3 6 18 4 8 32

1.5 - 10 mm (diameter) x 1- 5 cm length Material Porcine small intestinal submucosa (SIS) extracellular collagen matrix (ECM), sodium hyaluronate, and sodium alginate Porcine small intestinal submucosa (SIS) extracellular collagen matrix (ECM) Configuration Flat sheet Curled sheet Sterile/Single Use Sterile; single use Sterile; single use Sterility / Sterilization Method SAL 10-6 / Ethylene Oxide SAL 10-6 / Ethylene Oxide

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026